EUVIMEDEUVIMED entdecken
Crossref

Progress in Research on Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) and Bladder Cancer

Wei-Ming Fang, Chun Chen

annals of urologic oncology · 2019

DOI: 10.32948/auo.2019.01.22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift annals of urologic oncology, 2019. Verfasst von Wei-Ming Fang und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) was first discovered in 1987 and confirmed to be a protein that is mainly expressed on the surface of activated lymphocytes. CTLA-4 is expressed on the surface of T cells and binds to B7 expressed on antigen presenting cells(APCs) to potentially play a role in inhibiting lymphocyte proliferation. Inhibitors of CTLA-4 were developed to promote the anti-tumor effects of T cells and inhibit tumor growth. CTLA-4, as an immune checkpoint, has been realized as an important therapeutic target in bladder cancer. Two main CTLA-4 inhibitors are currently used: ipilimumab is a first-generation IgG1 monoclonal antibody that targets CTLA-4, and it is completely synthetic; tremelimumab, representing another class of CTLA-4 inhibitors, is a monoclonal antibody against CTLA-4 that acts similarly to ipilimumab and binds specifically to CTLA-4. The two types of CTLA-4 inhibitors were found to improve the treatment effect in patients with bladder cancer in comparison to conventional agents. To review this topic, we searched recently published related articles.

Zitieren

APA

Fang, W., & Chen, C. (2019). Progress in Research on Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) and Bladder Cancer. annals of urologic oncology. https://doi.org/10.32948/auo.2019.01.22

Vancouver

Fang W, Chen C. Progress in Research on Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) and Bladder Cancer. annals of urologic oncology. 2019. doi:10.32948/auo.2019.01.22

BibTeX
@article{Fang2019,
  author = {Fang, Wei-Ming and Chen, Chun},
  title = {Progress in Research on Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) and Bladder Cancer},
  journal = {annals of urologic oncology},
  year = {2019},
  doi = {10.32948/auo.2019.01.22}
}
Kostenlos starten →